Register Now
Course Information

Mastering the Management of Aortic Valve Disease: Imaging, Intervention and Innovation

December 3, 2021 - December 4, 2021
JW Marriott Essex House – New York, NY
and Live Stream

The management of patients with aortic valve disease is constantly evolving, highlighted by innovations in devices, surgical techniques, and imaging. In addition, guidelines, research studies and clinical trials are continually expanding the evidence base related to both management decisions and treatment outcomes from valve interventions, both transcatheter and surgical-implanted devices. These developments, in turn, have altered the clinical practice framework for approaching aortic valve disease quantification and treatments, resulting in some confusion regarding the optimal management strategies. This program is designed to bring together cardiologists, surgeons, and other healthcare providers to address the contemporary and future management of aortic valve disease and better define the role of transcatheter and surgical therapies. The course will emphasize case-based learning designed to engage learners in discussions, debates, and critical decision-making for this condition.

By attending, participants will be able to:

  • Describe the best practices for the management of patients with aortic valve disease.
  • Discuss the role of basic and advanced imaging techniques to assess patients with aortic valve disease.
  • Accurately assess options for treating difficult scenarios associated with aortic valve disease including transcatheter valve failure, minimally invasive valve replacement, and evaluation of surgical risks in shared decision making.
  • Discuss the pros and cons associated with transcatheter aortic valve replacement (TAVR) in various patient populations and review the management of potential complications.
  • Summarize the emerging innovations in technologies for TAVR along with results in clinical trials and describe their potential implications for clinical practice.

Who Should Attend?

This course is intended for cardiothoracic surgeons, cardiologists, interventional cardiologists, internists, nurses, physician assistants and all health care professionals involved in the evaluation, diagnosis and/or management of patients with aortic valve disease.

Cleveland Clinic has been ranked the nation’s No. 1 heart care program for 27 consecutive years by
U.S. News & World Report.